drug · small molecule
patient view →CEP-11981
Phase 2updated 2mo agoby $TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 1, with 1 investigational indication.
targets
Vascular endothelial growth factor receptorAngiopoietin-1 receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that